Meglumine Antimoniate
锑酸葡甲胺
Report date: 2022/01/14 13:23:58
Base Information
Drug NameMeglumine Antimoniate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A
Develop Information
Active CompaniesSanofiUniversity Of Antioquia
Inactive CompaniesUniversidad De SantanderThe University Of AkronPontificia Universidade Católica Do Rio Grande Do Sul +[5]
Active Indications
Inactive IndicationsN/A